Literature DB >> 33447875

Tensile strength assay comparing the resistance between two different autologous platelet concentrates (leucocyte-platelet rich fibrin versus advanced-platelet rich fibrin): a pilot study.

Martim de Almeida Nóbrega Correia Pascoal1, Nuno Bernardo Malta Dos Santos2, António Manuel Godinho Completo3, Gustavo Vicentis de Oliveira Fernandes4,5.   

Abstract

BACKGROUND: Since the leucocyte-platelet rich fibrin (L-PRF) was published in 2001, many studies have been developed, analyzing its properties, and also verifying new possibilities to improve it. Thereby, it emerges the advanced-platelet rich fibrin (A-PRF) with a protocol that optimizes the properties obtained by the L-PRF. Nonetheless, there is a gap in the literature to landmark the evolutive process concerning the mechanical properties in specific the resistance to tensile strength which consequently may influence the time for membrane degradation. Thus, this study had the goal to compare the resistance to the traction of membranes produced with the original L-PRF and A-PRF protocols, being the first to this direct comparison.
FINDINGS: The harvest of blood from a healthy single person, with no history of anticoagulant usage. We performed the protocols described in the literature, within a total of 13 membranes produced for each protocol (n = 26). Afterward, the membranes were prepared and submitted to a traction test assessing the maximal and the average traction achieved for each membrane. The data were analyzed statistically using the unpaired t test. Regarding average traction, A-PRF obtained a value of 0.0288 N mm-2 and L-PRF 0.0192 N mm-2 (p < 0.05 using unpaired t test). For maximal traction, A-PRF obtained 0.0752 N mm-2 and L-PRF 0.0425 N mm-2 (p < 0.05 using unpaired t test).
CONCLUSION: With this study, it was possible to conclude that indeed A-PRF has a significative higher maximal traction score and higher average traction compared to L-PRF, indicating that it had a higher resistance when two opposing forces are applied.

Entities:  

Keywords:  Fibrin; Platelet; Resistance; Rupture; Tensile strength

Year:  2021        PMID: 33447875      PMCID: PMC7809075          DOI: 10.1186/s40729-020-00284-w

Source DB:  PubMed          Journal:  Int J Implant Dent        ISSN: 2198-4034


  34 in total

1.  Platelet-rich fibrin application in dentistry: a literature review.

Authors:  Eduardo Borie; Daniel García Oliví; Iara Augusta Orsi; Katia Garlet; Benjamín Weber; Víctor Beltrán; Ramón Fuentes
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Lars Rasmusson; Tomas Albrektsson
Journal:  Trends Biotechnol       Date:  2009-01-31       Impact factor: 19.536

3.  Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction.

Authors:  Luigi Fabrizio Rodella; Gaia Favero; Ramon Boninsegna; Barbara Buffoli; Mauro Labanca; Giorgio Scarì; Luigi Sacco; Tiziano Batani; Rita Rezzani
Journal:  Microsc Res Tech       Date:  2011-08       Impact factor: 2.769

4.  Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells.

Authors:  Shahram Ghanaati; Patrick Booms; Anna Orlowska; Alica Kubesch; Jonas Lorenz; Jim Rutkowski; Constantin Landes; Robert Sader; Cj Kirkpatrick; Joseph Choukroun
Journal:  J Oral Implantol       Date:  2014-12       Impact factor: 1.779

5.  Optimized Platelet-Rich Fibrin With the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response.

Authors:  Masako Fujioka-Kobayashi; Richard J Miron; Maria Hernandez; Umadevi Kandalam; Yufeng Zhang; Joseph Choukroun
Journal:  J Periodontol       Date:  2016-09-02       Impact factor: 6.993

Review 6.  Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Tomasz Bielecki; Ryo Jimbo; Giovanni Barbé; Marco Del Corso; Francesco Inchingolo; Gilberto Sammartino
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

7.  Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study.

Authors:  Nelson R Pinto; Matias Ubilla; Yelka Zamora; Verónica Del Rio; David M Dohan Ehrenfest; Marc Quirynen
Journal:  Platelets       Date:  2017-07-20       Impact factor: 3.862

8.  The role of smoking and gingival crevicular fluid markers on coronally advanced flap outcomes.

Authors:  Başak Kaval; Diane E Renaud; David A Scott; Nurcan Buduneli
Journal:  J Periodontol       Date:  2013-05-31       Impact factor: 6.993

9.  Does Adding Silver Nanoparticles to Leukocyte- and Platelet-Rich Fibrin Improve Its Properties?

Authors:  Hooman Khorshidi; Pardis Haddadi; Saeed Raoofi; Parisa Badiee; Ali Dehghani Nazhvani
Journal:  Biomed Res Int       Date:  2018-05-27       Impact factor: 3.411

10.  Mechanical, chemical, structural analysis and comparative release of PDGF-AA from L-PRF, A-PRF and T-PRF - an in vitro study.

Authors:  Shravanthy Ravi; Muthukumar Santhanakrishnan
Journal:  Biomater Res       Date:  2020-09-11
View more
  2 in total

1.  Tensile Strength Essay Comparing Three Different Platelet-Rich Fibrin Membranes (L-PRF, A-PRF, and A-PRF+): A Mechanical and Structural In Vitro Evaluation.

Authors:  Mara Simões-Pedro; Pedro Maria B P S Tróia; Nuno Bernardo Malta Dos Santos; António M G Completo; Rogerio Moraes Castilho; Gustavo Vicentis de Oliveira Fernandes
Journal:  Polymers (Basel)       Date:  2022-03-29       Impact factor: 4.329

2.  Osteoconductive Properties of a Volume-Stable Collagen Matrix in Rat Calvaria Defects: A Pilot Study.

Authors:  Karol Alí Apaza Alccayhuaman; Stefan Tangl; Stéphane Blouin; Markus A Hartmann; Patrick Heimel; Ulrike Kuchler; Jung-Seok Lee; Reinhard Gruber
Journal:  Biomedicines       Date:  2021-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.